相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
Mical Paul et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2022)
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)
Marco Falcone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)
Giusy Tiseo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)
Giusy Tiseo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis
Ruyin Zhou et al.
BMJ OPEN (2021)
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Regional Spread of blaNDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities
Zena Lapp et al.
CLINICAL INFECTIOUS DISEASES (2021)
New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020
Jacqueline Findlay et al.
EMERGING INFECTIOUS DISEASES (2021)
Resilience of the Pitt Bacteremia Score: 3 Decades and Counting
Majdi N. Al-Hasan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Epidemiology of beta-Lactamase-Producing Pathogens
Karen Bush et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin et al.
LANCET INFECTIOUS DISEASES (2020)
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
Marco Falcone et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Cross-border spread of and blaNDM-1- and blaOXA-48 positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
Catherine Ludden et al.
EUROSURVEILLANCE (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Quantification and interpretation of attributable mortality in core clinical infectious disease journals
Maja von Cube et al.
LANCET INFECTIOUS DISEASES (2020)
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
Marco Falcone et al.
CRITICAL CARE (2020)
Zero or More: Methodological Challenges of Counting and Estimating Deaths Related to Antibiotic-resistant Infections
Elizabeth Temkin et al.
CLINICAL INFECTIOUS DISEASES (2019)
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study
Alessandro Russo et al.
JOURNAL OF INFECTION (2019)
A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis
Sabrina Sabino et al.
MSPHERE (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data
Miguel A. Hernan
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy
Francesco Menichetti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
M. Falcone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
Matthew E. Falagas et al.
EMERGING INFECTIOUS DISEASES (2014)
Infections with VIM-1 Metallo-β-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
Marco Falcone et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Guidelines for the prevention of intravascular catheter-related infections
NP O'Grady et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2002)